Dr Susan Moore Haefner, MD | |
1200 N Beaver St, Flagstaff, AZ 86001-3118 | |
(928) 773-2120 | |
(928) 213-2189 |
Full Name | Dr Susan Moore Haefner |
---|---|
Gender | Female |
Speciality | Pediatrics - Pediatric Critical Care Medicine |
Location | 1200 N Beaver St, Flagstaff, Arizona |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1912948530 | NPI | - | NPPES |
705347 | Medicaid | AZ | |
152394601 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2080P0203X | Pediatrics - Pediatric Critical Care Medicine | L4961 (Texas) | Secondary |
2080P0203X | Pediatrics - Pediatric Critical Care Medicine | 27097 (Arizona) | Primary |
Entity Name | Magella Medical Associates Billing Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083631071 PECOS PAC ID: 8729970215 Enrollment ID: O20041115001144 |
News Archive
Uterine fibroid embolization (UFE), a minimally invasive interventional radiology treatment for uterine fibroids, provides significant relief of symptoms for women whose focused ultrasound (FUS) treatment failed, according to a study released during the Society of Interventional Radiology's 33rd Annual Scientific Meeting in Washington, D.C. Primary care physicians and gynecologists can feel confident in informing patients that a failed FUS treatment does not require subsequent gynecological surgery.
Geisinger Health System, widely recognized for its implementation of innovative care models, is among the first healthcare organizations in the nation to deploy advanced technology that combines a Computer-Assisted Coding application with Natural Language Comprehension™ (NLC) in order to improve clinical documentation and coding accuracy.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data from its RNAi therapeutic program for the treatment of hemophilia and rare bleeding disorders.
Actavis, an international generic pharmaceuticals company, today announced that it has received final approval from the US Food & Drug Administration to market Zolpidem Tartrate Extended-Release Tablets USP, 12.5 mg CIV. Distribution of the product has commenced.
Researchers at Loyola University Health System, Maywood, Ill., and the University of Rochester Medical Center, Rochester, N.Y., found that the previously demonstrated survival benefit of ICDs following a heart attack can last up to 15 years.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Susan Moore Haefner, MD 1200 N Beaver St, Payer Credentialing, Flagstaff, AZ 86001-3118 Ph: (928) 773-2559 | Dr Susan Moore Haefner, MD 1200 N Beaver St, Flagstaff, AZ 86001-3118 Ph: (928) 773-2120 |
News Archive
Uterine fibroid embolization (UFE), a minimally invasive interventional radiology treatment for uterine fibroids, provides significant relief of symptoms for women whose focused ultrasound (FUS) treatment failed, according to a study released during the Society of Interventional Radiology's 33rd Annual Scientific Meeting in Washington, D.C. Primary care physicians and gynecologists can feel confident in informing patients that a failed FUS treatment does not require subsequent gynecological surgery.
Geisinger Health System, widely recognized for its implementation of innovative care models, is among the first healthcare organizations in the nation to deploy advanced technology that combines a Computer-Assisted Coding application with Natural Language Comprehension™ (NLC) in order to improve clinical documentation and coding accuracy.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data from its RNAi therapeutic program for the treatment of hemophilia and rare bleeding disorders.
Actavis, an international generic pharmaceuticals company, today announced that it has received final approval from the US Food & Drug Administration to market Zolpidem Tartrate Extended-Release Tablets USP, 12.5 mg CIV. Distribution of the product has commenced.
Researchers at Loyola University Health System, Maywood, Ill., and the University of Rochester Medical Center, Rochester, N.Y., found that the previously demonstrated survival benefit of ICDs following a heart attack can last up to 15 years.
› Verified 5 days ago
James Wallace Mathewson, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1330 N Rim Dr, Suite A, Flagstaff, AZ 86001 Phone: 928-779-7014 | |
Barbara L. Bosch, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 77 W Forest Ave, Suite 304, Flagstaff, AZ 86001 Phone: 928-214-3600 Fax: 928-214-3601 | |
Lee B Mcgarey, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 77 W Forest Ave, Suite 304, Flagstaff, AZ 86001 Phone: 928-214-3600 Fax: 928-214-3601 | |
Mark F Carroll, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1215 N Beaver St, Suite 201, Flagstaff, AZ 86001 Phone: 928-214-3920 Fax: 928-214-3924 | |
Dr. Julia Beth Eskuchen, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2920 N 4th St, Flagstaff, AZ 86004 Phone: 928-213-6100 Fax: 928-213-9351 | |
Ron L Tuckman, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 77 W Forest Ave, Suite 304, Flagstaff, AZ 86001 Phone: 928-214-3600 Fax: 928-214-3601 | |
Dr. Jennifer Ekdahl Cortes, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 2920 N 4th St, Flagstaff, AZ 86004 Phone: 928-522-9400 |